Coverage Authorization List
Brand Name![]() |
Generic Name | Effective Date | Requirements | Class |
---|---|---|---|---|
Zytiga | Abiraterone | 01/01/2018 |
|
Oncology |
Zykadia |
ceritinib |
01/01/2018 |
|
Oncology |
Zydelig |
Idelalisib |
01/01/2018 |
|
Oncology |
Zuplenz | ondansetron | 01/01/2017 |
|
Antiemetics |
Zulresso | brexanolone | 07/01/2019 |
|
Mental Health |
Ztlido | lidocaine topical system | 01/01/2019 |
|
Topical Anesthetics - Lidocaine Containing |
Zorvolex | Diclofenac | 01/01/2017 |
|
COX-2/NSAIDs |
Zorbtive | somatropin injection | 01/01/2017 |
|
GI Disorders |
Zonalon | doxepin | 10/01/2017 |
|
Topical Skin Product |
Zomig | zolmitriptan | 01/01/2017 |
|
Antimigraine |
Zometa | zoledronic acid | 01/01/2017 |
|
Oncology |
Zomacton | somatropin | 01/01/2017 |
|
Growth Hormone and Related Disorders |
Zolpimist | zolpidem | 01/01/2018 |
|
Sedative-Hypnotics |
Zolinza | Vorinostat | 01/01/2018 |
|
Oncology |
Zoladex | Goserelin | 01/01/2018 |
|
Hormonal Therapies |
Zohydro ER | hydrocodone bitartrate extended-release capsules | 03/01/2018 |
|
Opioid Analgesics - Extended-Release |
Zofran | ondansetron | 01/01/2017 |
|
Antiemetics |
Zirabev | bevacizumab-bvzr | 01/01/2018 |
|
Oncology |
Zipsor | Diclofenac | 01/01/2017 |
|
COX-2/NSAIDs |
Zioptan | tafluprost | 01/01/2017 |
|
Glaucoma |
Zinbryta | daclizumab | 01/01/2018 |
|
Multiple Sclerosis |
Ziextenzo | Pegfilgrastim-bmez | 01/01/2018 |
|
Neutropenia |
Ziana | clindamycin phosphate/tretinoin gel | 01/01/2017 |
|
Retinoids |
Ziagen | abacavir | 01/01/2018 |
|
HIV |
Zerit | stavudine | 01/01/2018 |
|
HIV |
Zepatier | elbasvir and grazoprevir | 01/01/2018 |
|
Hepatitis C |
Zenzedi | dextroamphetamine tablets | 01/01/2017 |
|
ADHD-Narcolepsy Agents |
Zenatane | Isotretinoin | 01/01/2017 |
|
Isotretinoins |
Zembrace Symtouch | sumatriptan | 01/01/2017 |
|
Antimigraine |
Zemaira | Alpha-1-proteinase Inhibitor | 01/01/2017 |
|
Alpha-1 Antitrypsin Deficiency |
Zelboraf | vemurafenib tablets | 01/01/2018 |
|
Oncology |
Zejula | niraparib | 01/01/2018 |
|
Oncology |
Zegerid | omeprazole/sodium bicarbonate | 03/20/2019 |
|
Proton Pump Inhibitors |
Zavesca | Miglustat | 01/01/2018 |
|
Lysosomal Storage Disorders |
Zarxio | filgrastim-sndz injection | 01/01/2017 |
|
Neutropenia |
Zaltrap | Ziv-Aflibercept | 01/01/2017 |
|
Oncology |
Zaclir | benzoyl peroxide | 09/01/2017 |
|
Topical Acne Products |
Yonsa | abiraterone | 01/01/2019 |
|
Oncology |
Yervoy | ipilimumab | 01/01/2017 |
|
Oncology |
Xyrem | sodium oxybate oral solution | 10/01/2017 |
|
Narcolepsy (Other) |
Xyosted | testosterone enanthate | 01/01/2019 |
|
Testosterone Products |
Xyntha | Antihemophilic factor VIII | 10/01/2017 |
|
Hemophilia |
Xylocaine | lidocaine 4% solution | 01/01/2019 |
|
Topical Anesthetics - Lidocaine Containing |
Xtandi | enzalutamide | 01/01/2018 |
|
Oncology |
Xtampza ER | oxycodone extended-release capsules | 03/01/2018 |
|
Opioid Analgesics - Extended-Release |
Xpovio | selinexor | 08/01/2019 |
|
Oncology |
Xospata | gilteritinib | 01/01/2019 |
|
Oncology |
Xopenex | Levalbuterol | 01/01/2017 |
|
Short-Acting Beta Agonists - Oral Inh |
Xolair | omalizumab injection for subcutaneous [SC] use | 01/01/2017 |
|
Allergic Asthma |
Xofluza | baloxavir | 01/01/2019 |
|
Influenza |